image: ©SewcreamStudio | iStock

Leaders from the G7, alongside Brazil, Egypt, India, Kenya, and the Republic of Korea, authorised a new way of reducing the global burden of the disease and improving survival outcomes.

Cancer remains one of the world’s leading causes of death, with nearly 10 million lives lost annually and cases expected to rise significantly by mid-century.

The statement highlights how demographic ageing, alongside environmental and behavioural risk factors, is likely to drive a sharp increase in demand for diagnosis and treatment unless stronger prevention and early detection measures are scaled up globally.

A focus of the agreement is accelerating international research cooperation. Leaders emphasised that no single country holds enough data alone to fully understand paediatric, adolescent, and young adult cancers. As a result, countries committed to improving interoperability between national cancer registries and research programmes.

Rather than relying on direct data transfer, the approach encourages secure and privacy-compliant systems that allow data to be analysed across borders using advanced tools such as artificial intelligence. This is expected to support faster insights while respecting national laws on data protection and intellectual property.

The initiative also aims to avoid duplication in research funding and to better align existing international and regional programmes. By strengthening coordination between cancer institutes, governments hope to accelerate the translation of laboratory discoveries into clinical care.

Another key pillar of the initiative is tackling cancers with poor survival outcomes. Leaders agreed on the importance of developing a shared international understanding of these cancers and building a coordinated research agenda.

Countries intend to explore ambitious targets for expanding screening programmes, with the goal of diagnosing more cases at earlier stages. In particular, efforts will focus on reducing mortality from lung cancer over the next decade through improved detection and intervention strategies.

The agreement also highlights the role of innovation, including digital health tools, advanced computing, and quantum technologies, in improving clinical trials and speeding up the delivery of new treatments to patients.

The commitments also address inequalities in access to high-quality care. Governments pledged to support stronger and more resilient health systems capable of delivering consistent cancer services, including prevention, treatment, and palliative care.

There is also an emphasis on expanding comprehensive cancer centres, which are seen as key hubs for research, education, and high-standard clinical care. These centres are expected to help bridge gaps between scientific progress and real-world treatment availability.

Digital technologies and artificial intelligence are also highlighted as tools that could improve early diagnosis, support clinical decision-making, and extend care to underserved populations, provided they are used responsibly and securely.

The statement concludes with a commitment to continued international engagement and regular review of progress.